FREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPING

Research Library ยท Compound Guide

Tesamorelin: Research Overview & Molecular Profile

Tesamorelin is a synthetic 44-amino-acid analog of human growth-hormone-releasing hormone (GHRH), structurally modified at the N-terminus by a hexenoyl (trans-3-hexenoic) group on the terminal tyrosine residue. In the research literature it is classified as a growth-hormone-releasing factor analog within the GHRH analog family. AurexBioLabs supplies Tesamorelin as a lyophilized research compound for in vitro and animal-model laboratory study only.

For Research Use Only. Not for human or veterinary use. Not a drug, food, or cosmetic. This page is educational reference material for qualified researchers and contains no medical advice, dosing, or health claims.

Important: Tesamorelin also exists as an FDA-approved prescription pharmaceutical (marketed under a brand name) for a specific human medical condition. The product supplied by AurexBioLabs is NOT that pharmaceutical product - it is a research-grade compound sold strictly for laboratory research use and is not intended for human use of any kind.

Tesamorelin Molecular Profile

Tesamorelin molecular profile
Compound typeSynthetic 44-amino-acid GHRH analog
Structural modificationN-terminal hexenoyl (trans-3-hexenoic) group on tyrosine
Molecular formulaC221H366N72O67S
Molecular weight~5135.8 g/mol
CAS number218949-48-5
Physical formLyophilized white powder

Research Context

In published preclinical literature, Tesamorelin is characterized as a stabilized GHRH analog studied in models of the GHRH signaling pathway. Research has examined the effect of its N-terminal modification on stability relative to native GHRH in laboratory assays. The research-grade Tesamorelin supplied here has not been evaluated by AurexBioLabs for, and is not intended for, any human or veterinary use. Any published human-clinical data pertains to the approved pharmaceutical product, not to research-grade material. Consult primary sources directly.

Handling & Laboratory Considerations

Storage

Lyophilized material stored frozen, protected from light.

Reconstitution (research context)

Bacteriostatic or sterile water per protocol; refrigerate reconstituted solution.

Stability

As a longer peptide, handle with care - minimize freeze-thaw and exposure to heat and light.

Quality & Verification at AurexBioLabs

Every batch of research-grade Tesamorelin is third-party HPLC and mass-spec verified with a published Certificate of Analysis. Confirm your vial by lot number at our verification page.

Frequently Asked Questions

Approximately 5135.8 g/mol.

218949-48-5.

It is a 44-amino-acid GHRH analog with an N-terminal hexenoyl modification that, in research characterization, affects its stability relative to native GHRH.

No. We supply a research-grade compound for laboratory use only; it is not the approved pharmaceutical product and is not for human use.

Yes - HPLC and mass-spec verified with a COA per batch.

Next Steps

Verification & catalog

For Research Use Only. Not for human or veterinary use. Not a drug, food, or cosmetic. This page is educational reference material for qualified researchers and contains no medical advice, dosing, or health claims.

Tesamorelin is sold for laboratory research use only. Not for human or veterinary use, diagnostic, or therapeutic purposes.